Screener Summaries Updates Institutions Sign In More Updates › Financing › TTRX Financing · Aug 18, 2026
Turn Therapeutics Inc. issued 579,664 shares of common stock to GEM Yield Bahamas Limited on August 13, 2026… TTRX Turn Therapeutics Inc.
Turn Therapeutics Inc. issued 579,664 shares of common stock to GEM Yield Bahamas Limited on August 13, 2026, following the full cashless exercise of a warrant for 1,192,207 shares. The transaction relied on Section 4(a)(2) registration exemption based on the investor's accredited status. Turn Therapeutics Inc. operates in the biotechnology industry, focusing on drug discovery and development.
More from Turn Therapeutics Inc. Turn Therapeutics releases investor presentation highlighting GX-03 Phase 2 data and $10.3M cash balance Oct 6, 2026 Turn Therapeutics appoints former CDC Director Robert Redfield as Chief Scientific Officer Sep 9, 2026 On August 14, 2026, Turn Therapeutics Inc. entered into securities purchase agreements with accredited investors to… Aug 17, 2026 Turn Therapeutics Inc. reported financial and operating results for the quarter ended June 30, 2026 Aug 12, 2026 Turn Therapeutics Inc. filed a Form 8-K on July 28, 2026, to furnish an updated investor presentation under Item 7.01… Jul 28, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
